ELIA, Leonardo
 Distribuzione geografica
Continente #
NA - Nord America 1.954
EU - Europa 413
AS - Asia 371
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
SA - Sud America 1
Totale 2.742
Nazione #
US - Stati Uniti d'America 1.952
CN - Cina 285
UA - Ucraina 168
IT - Italia 84
HK - Hong Kong 72
DE - Germania 40
IE - Irlanda 37
FI - Finlandia 27
GB - Regno Unito 21
FR - Francia 12
BE - Belgio 9
SE - Svezia 7
IN - India 5
KR - Corea 3
NL - Olanda 3
CA - Canada 2
GR - Grecia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AU - Australia 1
CH - Svizzera 1
EU - Europa 1
JP - Giappone 1
MD - Moldavia 1
MU - Mauritius 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
SG - Singapore 1
TR - Turchia 1
TW - Taiwan 1
Totale 2.742
Città #
Fairfield 340
Woodbridge 213
Houston 189
Ashburn 144
Cambridge 134
Jacksonville 133
Chandler 132
Seattle 121
Ann Arbor 119
Wilmington 83
Dearborn 73
Hong Kong 72
Princeton 68
Beijing 52
Nanjing 50
Dublin 37
Brescia 30
Helsinki 26
New York 26
Jinan 21
Nanchang 18
Des Moines 17
San Diego 17
Hebei 15
Shenyang 15
Changsha 14
Jiaxing 12
Ningbo 11
Shanghai 10
Brussels 9
Lanzhou 8
London 8
Tianjin 8
Haikou 7
Isola Vicentina 7
Taizhou 7
Zhengzhou 6
Guangzhou 5
Hangzhou 5
Verona 5
Kunming 4
Milan 4
San Francisco 4
Fuzhou 3
Orange 3
Sarezzo 3
Desio 2
Hefei 2
Kilburn 2
Monza 2
Norwalk 2
Pune 2
Redmond 2
Toronto 2
Amsterdam 1
Atlanta 1
Baotou 1
Canberra 1
Chengdu 1
Chisinau 1
Chongqing 1
Como 1
Cosenza 1
Foshan 1
Groningen 1
Grossmuehlingen 1
Gunzenhausen 1
Hounslow 1
Kocaeli 1
Lappeenranta 1
Los Angeles 1
Marseille 1
Mountain View 1
Nanning 1
Nuvolera 1
Orzivecchi 1
Paris 1
Redwood City 1
Riyadh 1
Rockville 1
Rome 1
Seoul 1
Taiyuan 1
Tokyo 1
Walnut 1
Wandsworth 1
Washington 1
Totale 2.337
Nome #
Epigenetics and vascular diseases 126
Ferritin, cellular iron storage and regulation 124
T cell costimulation blockade blunts pressure overload-induced heart failure 116
UHRF1 epigenetically orchestrates smooth muscle cell plasticity in arterial disease 111
Epigenetics and Vascular Diseases: Influence of Non-coding RNAs and Their Clinical Implications 108
Circular RNAs and heart failure: new players for an old disease 107
MicroRNA 143-145 deficiency impairs vascular function 107
Heart failure: Targeting transcriptional and post-transcriptional control mechanisms of hypertrophy for treatment 105
MicroRNA-133 controls cardiac hypertrophy 105
Genetic vaccines against Ep-CAM break tolerance to self in a limited subset of subjects: Initial identification of predictive biomarkers 104
The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: Correlates with human disease 103
A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion 102
DNA and adenoviral vectors encoding carcinoembryonic antigen fused to immunoenhancing sequences augment antigen-specific immune response and confer tumor protection 100
MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro 97
RNA (Epi)genetics in cardiovascular diseases 96
MicroRNAs and pulmonary hypertension: A tight link 95
Arterial remodeling and atherosclerosis: MiRNAs involvement 95
CD4+CD25+ regulatory T-cell-inactivation in combination with adenovirus vaccines enhances T-cell responses and protects mice from tumor challenge 95
MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines 95
The involvement of epigenetics in vascular disease development 94
Vectors encoding carcinoembryonic antigen fused to the B subunit of heat-labile enterotoxin elicit antigen-specific immune responses and antitumor effects 90
Reciprocal regulation of microrna-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions 87
MiR-143/145 deficiency attenuates the progression of atherosclerosis in Ldlr-/- mice 86
Circ_Lrp6, a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function 85
TGFβ triggers miR-143/145 transfer from smooth muscle cells to endothelial cells, thereby modulating vessel stabilization 66
MicroRNA-133 modulates the β1-adrenergic receptor transduction cascade 61
miR-128-3p Is a Novel Regulator of Vascular Smooth Muscle Cell Phenotypic Switch and Vascular Diseases 59
miR-9-5p is involved in the rescue of stress-dependent dendritic shortening of hippocampal pyramidal neurons induced by acute antidepressant treatment with ketamine 37
Frailty and cognitive impairment in elderly patients: miRNAs as new biomarkers (MATCH-In project) 34
The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell–monocyte crosstalk and protects against atherosclerosis via the NF-κB pathway 32
microRNAs as possible biomarkers of frailty and cognitive impairment: the MATCH-In project 26
rs41291957 controls miR-143 and miR-145 expression and impacts coronary artery disease risk 22
microRNAs as new biomarkers in frailty associated with cognitive impairment in elderly patients (MATCH-In project) 21
Aggravation of pulmonary fibrosis after knocking down the Aryl hydrocarbon receptor in the Insulin-like growth factor 1 receptor pathway 19
Vascular malformation rupture in a patient affected by Costello syndrome 10
Epigenetics and Vascular Disease 7
Editorial: Emerging roles of miRNAs in cardiovascular disease 6
The role of epigenetics in cardiovascular disease 3
Totale 2.836
Categoria #
all - tutte 12.934
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.934


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019162 0 0 0 0 0 0 0 0 0 0 95 67
2019/2020952 107 21 30 93 57 127 135 92 73 142 31 44
2020/2021440 10 61 19 46 29 38 16 51 43 58 53 16
2021/2022331 29 54 20 13 2 7 33 21 22 41 22 67
2022/2023318 55 0 2 30 34 81 2 42 48 7 9 8
2023/2024196 16 4 14 25 7 33 7 9 79 1 1 0
Totale 2.836